Dr. Jamie Cesaretti, MD

• Radiation Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• St. Lukes-roosevelt Hospital

  Internship Hospital

• Icahn School Of Medicine At Mount Sinai

  Residency Hospital, 2004

• Saint Luke's Roosevelt Hospital

  Internship Hospital, 2000

• State University Of New York At Stony Brook

  Medical School, 1999

• English

• Chinese

• Spanish

• (125)I monotherapy using D90 implant doses of 180 Gy or greater, 2008 Jan

• Possession of ATM Sequence Variants as Predictor for Late Normal Tissue Responses in Breast Cancer Patients Treated with Radiotherapy, 2007 May 1

• Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma, 2008 Feb

• Distant and local recurrence in patients with biochemical failure after prostate brachytherapy, 2009 Apr

• Johns Hopkins Textbook of Prostate Cancer Treatment, 2008

• Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy, 2009 Jun

• Effect of Radiotherapy Planning Complexity on Survival of Elderly Patients with Unresected Localized Lung Cancer, 2010 Oct

• Local Control Following Permanent Prostate Brachytherapy: Effect of High Biologically Effective Dose on Biopsy Results and Oncologic Outcomes, 2009 Jul

• Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at 7 years of follow-up, 2007 Aug

• Prognostic Significance of 5-Year PSA Value for Predicting Prostate Cancer Recurrence After Brachytherapy Alone and Combined with Hormonal Therapy and/or External Beam Radiotherapy, 2008 Dec

• Brachytherapy for patients with inflammatory bowel disease, 2006 Oct 1

• Combined Modality Treatment in the Management of High Risk Prostate Cancer, 2004 Aug 1

• Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation, 2006 Nov

• Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?, Feb 2010

• Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancer, 2007 Jan

• Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response, 2009 Aug

• Do high radiation doses in locally advanced prostate cancer patients treated with (103)Pd implant plus external beam irradiation cause increased urinary, rectal, and sexual morbidity?, 2009 Oct

• Disease-specific survival following the brachytherapy management of prostate cancer, 2006 Mar 1

• Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications, 2003 Jun 1

• Brachytherapy. Book Chapter, Prostate Cancer: Principles and Practice, Ed by Kirby R, Partin AW, Feneley M, Parsons JK, 1/2005

• A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy, 2007 May 8

• Brachytherapy for Prostate Cancer, 2007 Sept

• Does a prior transurethral resection of the prostate compromise brachytherapy quality: a dosimetric analysis, 2004 Oct 1

• Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function, 2006 Dec

• Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer, 2008 Jul

• Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer., Aug 2010

• Radiosurgery for Thoracic Malignancies, 2008 Feb

• Urinary symptom flare following I-125 prostate brachytherapy, 2003 Jul 1

• Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases, 2012 Jun

• ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer, 2005 Jan 1

• There is No Correlation Between Erectile Dysfunction and Dose to Penile Bulb and Neurovascular Bundles Following Real-Time Low-Dose Rate Prostate Brachytherapy, 2009 Apr

• Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS, 2007 Jan

• Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and post-treatment biopsy results, 2006 Feb 1

• Prostate brachytherapy preserves erectile function, Aug 2007

• Does Neoadjuvant Hormonal Therapy Improve Urinary Function When Given to Men With Large Prostates Undergoing Prostate Brachytherapy?, 2009 Dec

• ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy, 2006 Mar

• Urinary Morbidity Following Post-brachytherapy Transurethral Resection of the Prostate, 2005 Mar

• Genetic predictors of adverse radiotherapy effects: the Gene-PARE project, 2006 Jul 1

• Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control, 2006 Oct

• Acceptability and preliminary feasibility of an internet/CD-ROM-based education and decision program for early-stage prostate cancer patients: randomized pilot study, 2012 Jan

• Radiotherapy planning complexity and survival after treatment of advanced stage lung cancer in the elderly, 2009 June

• ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy, 2006 Mar 1

• TGFB1 Single Nucleotide Polymorphisms are Associated with Adverse Quality of Life in Prostate Cancer Patients Treated with Radiotherapy, 2007 Aug

• Update on Prostate Brachytherapy: Long-term Outcomes and Treatment-related Morbidity., June 2011

• Radiation Dose Predicts for Biochemical Control in Intermediate-Risk Prostate Cancer Patients Treated with Low-Dose-Rate Brachytherapy, 2009 Mar